Lipoprotein lipase (LPL), CD36 (also known as a fatty acid translocase, FAT), fatty acid transport protein family (FATPs), and plasma membrane fatty acid-binding proteins (FABPpm) are used to acquire diet-derived FAs from the bloodstream by lipolysis in specific cancer cells, such as non-small cell lung cancer (NSCLC), triple-negative breast cancer, liposarcoma, prostate cancer (PCa), etc. (7, 8). This evidence concerns the gene CD36 and triple-negative breast carcinoma.